TREATMENT OUTCOMES OF PACLITAXEL–CARBOPLATIN–BEVACIZUMAB FOR RECURRENT OR METASTATIC EPITHELIAL OVARIAN CANCER AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ. 2026;67(Số CĐ12- Bệnh viện Ung bướu Nghệ An). doi:10.52163/yhc.v67iCD12.6150